Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Cord Blood Takes Hit on Secondary Offering

publication date: Nov 8, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
On Friday, China Cord Blood Corporation priced a secondary issue of 8,050,000 ordinary shares at $4.50 per share, a steep 20% discount to the previous close of $5.66. Shareholders didn’t like the size of the discount and reacted by selling off their holdings of the company. The shares plunged $1.69 lower to $3.97, a 30% loss on very heavy volume. More details....

Stock Symbol: (NYSE: CO)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...